Harmonization of asia bridging study 2013 fip/aaps/tfda sponsored workshop report and future prospectives
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: HU, Oliver (National Defense Medical Center, School of Pharmacy, Taipei, China Taiwan)
The majority of medicines are not currently developed for the exclusive use in one country, and there is a continuing debate on how best to use clinical data that are obtained from global studies so as to avoid duplicative testing, thus reducing delay in availability of medicines and increasing the cost of development. There are a number of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.